SCHEMBL685180

SCHEMBL685180

BB(B)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL882948 0.83
SCHEMBL11959793 0.72
SCHEMBL20226853 0.72
SCHEMBL13909670 0.72
SCHEMBL14563389 0.72
SCHEMBL15218470 0.72
SCHEMBL10259066 0.72
SCHEMBL19219828 0.72
SCHEMBL18506487 0.72
SCHEMBL15195117 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348904-A1 SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS BANK OF AMERICA, N.A. 2023-11-02 US disclosed
US-20230134116-A1 CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLS PROTOMER TECHNOLOGIES, INC. 2023-05-04 US disclosed
WO-2022081911-A1 LINKER COMPOUNDS COMPRISING AMIDE BONDS MPEG LA, L.L.C. (US) 2022-04-21 WO disclosed
US-20190202991-A1 ENERGY CONVERSION DEVICES INCLUDING STABLE IONENES SIMON FRASER UNIVERSITY (CA) 2019-07-04 US disclosed
US-9890164-B2 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators PURDUE PHARMA, L.P. (US) 2018-02-13 US disclosed
US-20170216282-A1 Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders GALDERMA LABORATORIES INC 2017-08-03 US disclosed
EP-2867255-B1 METHOD FOR THE SELECTION AND PRODUCTION OF TAILOR-MADE, SELECTIVE AND MULTI-SPECIFIC THERAPEUTIC MOLECULES COMPRISING AT LEAST TWO DIFFERENT TARGETING ENTITIES AND USES THEREOF HOFFMANN LA ROCHE (CH) 2017-07-19 EP disclosed
US-20170182189-A1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES GENZYME CORPORATION 2017-06-29 US disclosed
US-20170186971-A1 Compound, Light-Emitting Element, Display Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-06-29 US disclosed
US-20160380203-A1 DIBENZOSUBERANE-BASED ELECTRON-TRANSPORT MATERIALS JENEKHE SAMSON A (US) 2016-12-29 US disclosed
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2009-12-03 US disclosed
US-7507509-B2 Electrophotographic photoreceptor, and image forming method, image forming apparatus and process cartridge using the electrophotographic photoreceptor RICOH COMPANY, LTD. (JP) 2009-03-24 US disclosed
US-20090060852-A1 Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging GALDERMA LABORATORIES INC. 2009-03-05 US disclosed
US-7491741-B2 Diaminopropionic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2009-02-17 US disclosed
US-7439241-B2 Compounds, formulations, and methods for treating or preventing rosacea GALDERMA LABORATORIES, INC. (US) 2008-10-21 US disclosed
US-7410975-B2 Small molecule toll-like receptor (TLR) antagonists COLEY PHARMACEUTICAL GROUP, INC. (US) 2008-08-12 US disclosed
US-7354928-B2 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-04-08 US disclosed
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-06 US disclosed
US-20070155671-A1 Diaminopropionic acid derivatives FOTOUHI NADER 2007-07-05 US disclosed
US-7217728-B2 Diaminopropionic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2007-05-15 US disclosed